Investigating the role of platelets in brain tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the role of platelets in the progression of brain neoplasms, particularly gliomas. It focuses on understanding how platelets may influence tumor behavior, including metastasis and angiogenesis, through the collection of tumor tissue and blood samples. The research aims to clarify the interactions between platelets and tumor cells in solid tumors, contributing to the broader understanding of cancer biology. The study does not involve any therapeutic interventions but rather observational data collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient to undergo excision or biopsy of a brain or medullary tumor
* Patient over 18 years old
* Express consent to participate in the study
* Affiliate member of the Social Security system

Exclusion Criteria:

* Tumor sample volume not allowing the performance of additional analyzes
* Patient benefiting from a legal protection measure
* Pregnant or breastfeeding woman

Where it's running

• Fondation A De Rothschild
  Paris, France Recruiting

Study contacts

• Principal investigator: Pierre BOURDILLON, MD — Fondation A. de Rothschild
• Study coordinator: Amélie YACHITZ, MD
• Email: ayavchitz@for.paris
• Phone: (0)148036454

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• YN003 injection in glioma patients

  This phase 1 study tests whether YN003 injected IV is safe and tolerable for adults with recurrent or progressive glioma, and to explore how the drug behaves in the body and any early signs of activity.

  Recruiting at 2 sites Phase 1 Beijing Inno Medicine Co., Ltd. · Los Angeles, California and 4 other locations · NCT07929909

• Entrectinib treatment for patients with ROS1-positive cancers

  This study is testing if the drug entrectinib can help people with different types of cancers that have a ROS1 gene fusion, including adults and kids, to see if it works better than what’s currently available.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770544

• Brain connectome project in adults with brain glioma undergoing surgery

  This registry collects MRI data and clinical information from adults with glioma to see how brain networks relate to surgery and recovery.

  Recruiting Northwell Health · New York, New York · NCT07927595

• Proton vs. Photon Radiation for Certain Grade 2–3 Gliomas

  This study tests whether proton therapy can better preserve thinking and memory than photon therapy for adults with IDH-mutated grade 2–3 gliomas who need radiation.

  Recruiting at 2 sites University Hospital, Essen · Essen and 1 other locations · NCT07750457

• Connectome-guided network planning for brain tumor surgery in eloquent areas

  This study tests whether using patient-specific brain network maps from diffusion MRI can help surgeons plan and guide brain tumor removal in eloquent areas.

  Recruiting ARNAS Civico Di Cristina Benfratelli Hospital · Palermo, PA · NCT07717827

• AI-powered analysis of brain MRI to help glioma care

  Doctors will use AI to study existing MRI scans and patient data from adults with glioma to see if it can help with non-invasive diagnosis and treatment planning.

  Recruiting Università degli Studi di Trento · Trento · NCT07703761

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.